Dr. Ashraf Abdelhamin Almashhrawi, MD

Dr. Almashhrawi practices at SSM Health St. Mary's Hospital - Jefferson City in Jefferson City, Missouri, part of SSM Health Care.

Dr. Almashhrawi's NPI, 1447247077, was assigned on September 29, 2005. Dr. Almashhrawi holds Missouri license 2011007590.

Dr. Almashhrawi's primary practice is SSM Health St. Mary's Hospital - Jefferson City, at 2505 Mission Drive, Jefferson City, MO 65109 in Cole County. The practice phone is (573) 681-3000.

Dr. Almashhrawi's primary practice is SSM Health St. Mary's Hospital - Jefferson City in Jefferson City, Missouri, part of SSM Health Care. The medical group on file is SSM Health Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Almashhrawi practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Almashhrawi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Almashhrawi's licenses on file in 2 states: Missouri and Arizona.

CMS data shows 838 Medicare services from Dr. Almashhrawi across 10 procedure codes in 2024, for 377 Medicare patients. Medicare paid $77,074 for them.

CMS counts 377 Medicare patients who saw Dr. Almashhrawi in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Almashhrawi's median patient age at 57, with 56% women.

In 2024, Dr. Almashhrawi wrote 1,219 Medicare Part D claims for 322 patients. 89% of them were for generic drugs. CMS names the drug for 1,094 of them, across 20 drugs with 11 or more claims each, at $200,043 in total drug cost. In 2023, CMS named 987 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Almashhrawi for performance year 2024, reported as part of a group. Dr. Almashhrawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Almashhrawi, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Almashhrawi, published from 2013 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Liver Diseases and Pregnancy Complications. Dr. Almashhrawi has published most often in World J Gastroenterol. Dr. Almashhrawi's most frequent co-authors are Rubayat Naila Rahman, MD, MPH, Khulood T. Ahmed, MD and Ghassan Mohamad Hammoud, MBCHB, MD, MPH.

CMS Open Payments shows 34 general payments to Dr. Almashhrawi from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 62% of the total. Covidien LP paid the most, $724.